A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

A U.S. Senator from Indiana says reliance on China for ag inputs makes the industry more vulnerable. Republican Todd Young ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to ...

To prevent dominance by an acknowledged adversary, the National Security Commission on Emerging Biotechnology (NSCEB) calls for a two-track strategy that helps American companies innovate more quickly ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...